What is Beijing Strong Biotechnologies,Inc.'s (300406.SZ) StockRank?

MoatMap's StockRank for Beijing Strong Biotechnologies,Inc. (300406.SZ) is 86/100, with a Strong Buy signal. This is a composite score combining Quality (65), Value (45), and Momentum (63) factor ranks across MoatMap's 20,000+ stock universe.

Does Beijing Strong Biotechnologies,Inc. have an economic moat?

Beijing Strong Biotechnologies,Inc. (300406.SZ) has a Quality factor score of 65/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Beijing Strong Biotechnologies,Inc. a buy, hold, or sell?

MoatMap's current signal for Beijing Strong Biotechnologies,Inc. (300406.SZ) is Strong Buy, based on a StockRank of 86/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Beijing Strong Biotechnologies,Inc. in?

Beijing Strong Biotechnologies,Inc. (300406.SZ) operates in the Healthcare sector, specifically the Diagnostics & Research industry (China).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

300406.SZ

STRONG BUYREMOVE

Beijing Strong Biotechnologies,Inc. · Healthcare · China · $1.0B · Avg Vol: $8M/d

StockRank

P/E (TTM)

31.9x

ROE

5.2%

D/E

0.3x

Dividend %

6.1%

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

Beijing Strong Biotechnology faces severe domestic pricing pressures from China's volume-based procurement (VBP) policies, limiting its pricing power.

COMPANY DESCRIPTION

Beijing Strong Biotechnologies, Inc. develops and manufactures in vitro diagnostic (IVD) reagents, calibrators, and automated clinical chemistry analyzers. The company is a market leader in China's clinical chemistry sector, known for its high-quality diagnostic reagents and extensive hospital distribution network. Its strategic OEM partnerships with global IVD giants like Beckman Coulter and Abbott Laboratories validate its technology and secure stable revenue streams.

FINANCIAL SUMMARY (USD)

Year	2022	2023	2024	2025	CAGR
Revenue	223M	257M	245M	200M	-3.6%
EPS	0.10	0.13	0.14	0.05	-21.8%
Shares	589M	588M	588M	586M	-0.4%
Debt	163M	168M	173M	159M	-0.8%
Equity	483M	550M	610M	560M	5.0%
Op CF	59M	86M	91M	84M	12.6%
Inv CF	-65M	-19M	-3M	-70M	—
Fin CF	-2M	-11M	-26M	-101M	—

PRICE (1M)-13.1%

SMA 50SMA 200

$1.68

RSI (14)

41.1

52W High

$2.24

From 52W High

0.8%

SCORE BREAKDOWN

Quality

ROIC

5.9%59.4

ROE

5.2%57.0

GP/Assets

21.6%49.5

Op. Margin

38.3%96.0

FCF/Assets

2.4%59.5

Piotroski

—83.4

Int. Cover

5.8x56.5

D/E Ratio

0.28x45.0

Current Ratio

12.18x90.1

Value

P/E (TTM)

31.9x34.6

EV/EBITDA

13.7x30.9

P/FCF

379.6x20.2

P/B

1.7x60.6

P/S

4.9x41.9

Div Yield

6.1%95.9

Momentum

52W High %

75%65.4

RS 6M

-21%54.7

SMA 50/200

0.95x48.8

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

—90.1

Q Growth

27%67.7

FUNDAMENTALS

Market Cap

$1.0B

P/E (Forward)

9.5x

Gross Margin

79.3%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 300406.SZ are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
300406.SZ	Beijing Strong Biotechnologies,Inc.(you)	$1.0B	86	STRONG BUY
300685.SZ	Amoy Diagnostics Co., Ltd.	$1.2B	80	BUY
300244.SZ	Dian Diagnostics Group Co.,Ltd.	$1.6B	78	BUY
6127.HK	Joinn Laboratories(China)Co.,Ltd.	$1.7B	77	BUY
603882.SS	Guangzhou Kingmed Diagnostics Group Co., Ltd.	$1.8B	67	BUY
9960.HK	Kindstar Globalgene Technology, Inc.	$139M	70	BUY
300463.SZ	Maccura Biotechnology Co.Ltd	$845M	33	SELL
2427.HK	Guanze Medical Information Industry (Holding) Co., Ltd.	$526M	42	HOLD
300676.SZ	BGI Genomics Co., Ltd.	$2.3B	37	HOLD
603716.SS	Thalys Medical Technology Group Corporation	$568M	31	SELL

Peer medians: ROE 4.7% · P/E 27.6x · Gross margin 53.0%

Beijing Strong Biotechnologies,Inc. (300406.SZ) — Stock Score Summary

Beijing Strong Biotechnologies,Inc. (300406.SZ) has a MoatMap StockRank of 86/100 based on Quality (65/100), Value (45/100), and Momentum (63/100) factor scores. The current signal is STRONG BUY. Beijing Strong Biotechnology faces severe domestic pricing pressures from China's volume-based procurement (VBP) policies, limiting its pricing power.

Key Financial Metrics

Price	$1.68
Market Cap	$1.0B
P/E (TTM)	31.92
P/E (Forward)	9.50
Price/Book	1.73
Return on Equity	5.2%
Return on Invested Capital	5.9%
Debt/Equity	28.05
Gross Margin	79.3%
Operating Margin	38.3%
Revenue Growth	4.7%
Dividend Yield	6.1%
Free Cash Flow	$3M

Beijing Strong Biotechnologies,Inc. operates in the Diagnostics & Research industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Beijing Strong Biotechnologies,Inc.’s (300406.SZ) StockRank?: MoatMap’s StockRank for Beijing Strong Biotechnologies,Inc. (300406.SZ) is 86/100, with a Strong Buy signal. It is a composite of Quality (65), Value (45), and Momentum (63) factor ranks across MoatMap’s 20,000+ stock universe.
Does Beijing Strong Biotechnologies,Inc. have an economic moat?: Beijing Strong Biotechnologies,Inc. (300406.SZ) has a Quality factor score of 65/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Beijing Strong Biotechnologies,Inc. a buy, hold, or sell?: MoatMap’s current signal for Beijing Strong Biotechnologies,Inc. (300406.SZ) is Strong Buy, based on a StockRank of 86/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Beijing Strong Biotechnologies,Inc. in?: Beijing Strong Biotechnologies,Inc. (300406.SZ) operates in the Healthcare sector, specifically the Diagnostics & Research industry (China).